1. Home
  2. RDY
  3. RDY News

Latest Dr. Reddy's Laboratories Ltd (RDY) News on June 2, 2025

Dr Reddy's Laboratories Ltd (RDY) Full Year 2025 Earnings Call Highlights: Record Revenue and ...
RDY

GuruFocus.com

21 days ago

Dr Reddy's Laboratories Ltd (RDY) Full Year 2025 Earnings Call Highlights: Record Revenue and ...

RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up
RDY

Zacks

21 days ago

RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up

RDY

Morningstar Research

24 days ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Q4 & Full Year FY25 Financial Results
RDY

Business Wire

24 days ago

Dr. Reddy’s Q4 & Full Year FY25 Financial Results

RDY

Morningstar Research

a month ago

Analyst Report: Dr. Reddy's Laboratories Limited

RDY

MT Newswires

2 months ago

Dr Reddy's Says Reported Job Cuts 'Factually Incorrect'

Dr. Reddy’s Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires
RDY

Insider Monkey

2 months ago

Dr. Reddy’s Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires

RDY

Morningstar Research

2 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia
RDY

PR Newswire

2 months ago

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
RDY

Business Wire

2 months ago

Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection
RDY

TipRanks

3 months ago

Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection

Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag
RDY

Business Wire

3 months ago

Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?
RDY

Insider Monkey

3 months ago

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?
RDY

Insider Monkey

3 months ago

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?

Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
RDY

Pharmaceutical Technology

4 months ago

Dr Reddy’s and Shanghai Henlius sign agreement for HLX15

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe
RDY

Business Wire

4 months ago

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.
RDY

PR Newswire

4 months ago

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down
RDY

Zacks

4 months ago

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down

Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...
RDY

GuruFocus.com

4 months ago

Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business
RDY

Benzinga

4 months ago

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business

RDY

Morningstar Research

4 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Q3 & 9MFY25 Financial Results
RDY

Business Wire

4 months ago

Dr. Reddy’s Q3 & 9MFY25 Financial Results

Dr. Reddy’s Laboratories Allocates Equity Shares to Employees
RDY

TipRanks

5 months ago

Dr. Reddy’s Laboratories Allocates Equity Shares to Employees

Dr. Reddy’s Boosts Workforce with Equity Allotment
RDY

TipRanks

6 months ago

Dr. Reddy’s Boosts Workforce with Equity Allotment

Why Dr. Reddy’s Laboratories Limited (RDY) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
RDY

Insider Monkey

6 months ago

Why Dr. Reddy’s Laboratories Limited (RDY) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Dr. Reddy’s Launches Innovative Cancer Drug in India
RDY

TipRanks

6 months ago

Dr. Reddy’s Launches Innovative Cancer Drug in India

Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
RDY

Business Wire

6 months ago

Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market
RDY

Business Wire

6 months ago

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market

Dr. Reddy’s Gains Strong Rating Amid Robust Growth
RDY

TipRanks

6 months ago

Dr. Reddy’s Gains Strong Rating Amid Robust Growth

Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow
RDY

Zacks

7 months ago

Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow

Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and ...
RDY

GuruFocus.com

7 months ago

Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and ...

RDY

Morningstar Research

7 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Q2 & H1FY25 Financial Results
RDY

Business Wire

7 months ago

Dr. Reddy’s Q2 & H1FY25 Financial Results

RDY

Morningstar Research

7 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
RDY

Business Wire

7 months ago

Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year

Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month
RDY

Business Wire

8 months ago

Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month

Dr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy Trial
RDY

TipRanks

8 months ago

Dr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy Trial

Dr. Reddy’s Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years
RDY

Insider Monkey

8 months ago

Dr. Reddy’s Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
RDY

Business Wire

8 months ago

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma

Dr. Reddy’s Unveils New Danish Subsidiary
RDY

TipRanks

8 months ago

Dr. Reddy’s Unveils New Danish Subsidiary

Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
RDY

Business Wire

8 months ago

Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries

Dr. Reddy’s Acquires Global NRT Leader Nicotinell
RDY

TipRanks

8 months ago

Dr. Reddy’s Acquires Global NRT Leader Nicotinell

Dr. Reddy’s Expands Portfolio with $620M Investment
RDY

TipRanks

8 months ago

Dr. Reddy’s Expands Portfolio with $620M Investment

Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials
RDY

Pharmaceutical Technology

9 months ago

Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
RDY

Business Wire

9 months ago

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug

RDY

Morningstar Research

10 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
RDY

Business Wire

10 months ago

Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar

Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat
RDY

Zacks

10 months ago

Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat

Dr. Reddy’s Q1FY25 Financial Results
RDY

Business Wire

10 months ago

Dr. Reddy’s Q1FY25 Financial Results

RDY

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
RDY

Business Wire

a year ago

Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business

Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities
RDY

Business Wire

a year ago

Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities

Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
RDY

Business Wire

a year ago

Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America

Alvotech and Dr Reddy’s partner to commercialise AVT03
RDY

Pharmaceutical Technology

a year ago

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
RDY

Business Wire

a year ago

Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
RDY

Zacks

a year ago

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

RDY

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript
RDY

Insider Monkey

a year ago

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript

RDY

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow
RDY

Zacks

a year ago

Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow

Dr. Reddy’s Q4 & Full Year FY24 Financial Results
RDY

Business Wire

a year ago

Dr. Reddy’s Q4 & Full Year FY24 Financial Results

Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.
RDY

Business Wire

a year ago

Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
RDY

GlobeNewswire

a year ago

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India

Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK
RDY

Business Wire

a year ago

Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
RDY

Zacks

a year ago

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term
RDY

Zacks

a year ago

Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term

Is There Any Hope for Cassava Sciences Stock?
RDY

Motley Fool

a year ago

Is There Any Hope for Cassava Sciences Stock?

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
RDY

Zacks

a year ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Aptiv to Present at Wolfe Research Global Auto and Auto Tech Conference
RDY

Business Wire

a year ago

Aptiv to Present at Wolfe Research Global Auto and Auto Tech Conference

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2024 Earnings Call Transcript
RDY

Insider Monkey

a year ago

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2024 Earnings Call Transcript

Hubbell Incorporated (NYSE:HUBB) Q4 2023 Earnings Call Transcript
RDY

Insider Monkey

a year ago

Hubbell Incorporated (NYSE:HUBB) Q4 2023 Earnings Call Transcript

PulteGroup, Inc. (NYSE:PHM) Q4 2023 Earnings Call Transcript
RDY

Insider Monkey

a year ago

PulteGroup, Inc. (NYSE:PHM) Q4 2023 Earnings Call Transcript

Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates
RDY

Zacks

a year ago

Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates

EBay to Pay $59 Million in Settlement Over Pill Presses
RDY

The Wall Street Journal

a year ago

EBay to Pay $59 Million in Settlement Over Pill Presses

$4 Million Bucks Will Buy You This Type of Retirement If You Stop Working at 55
RDY

SmartAsset

a year ago

$4 Million Bucks Will Buy You This Type of Retirement If You Stop Working at 55

Dr. Reddy’s Q3 & 9M FY24 Financial Results
RDY

Business Wire

a year ago

Dr. Reddy’s Q3 & 9M FY24 Financial Results

RDY

Reuters

a year ago

Nigeria dollar bonds drop amid FX adjustment, exposure woes

Here's Why Axon Enterprise (AXON) Fell More Than Broader Market
RDY

Zacks

a year ago

Here's Why Axon Enterprise (AXON) Fell More Than Broader Market

Tradeweb Markets (TW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
RDY

Zacks

a year ago

Tradeweb Markets (TW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

RDY

Reuters

a year ago

UPDATE 1-Indian pharma firm Dr Reddy's beats Q3 profit view on strong US, European businesses

RDY

Reuters

a year ago

India's Dr Reddy's beats Q3 profit estimates on strong US sales

Expedia (EXPE) Outpaces Stock Market Gains: What You Should Know
RDY

Zacks

a year ago

Expedia (EXPE) Outpaces Stock Market Gains: What You Should Know

Spain’s Top Renewable Fund Expands in US by Acquiring Heelstone
RDY

Bloomberg

a year ago

Spain’s Top Renewable Fund Expands in US by Acquiring Heelstone

Why Domino's Pizza (DPZ) is Poised to Beat Earnings Estimates Again
RDY

Zacks

a year ago

Why Domino's Pizza (DPZ) is Poised to Beat Earnings Estimates Again

Denison Mine's (DNN) JV to Restart McClean Lake Mining Activity
RDY

Zacks

a year ago

Denison Mine's (DNN) JV to Restart McClean Lake Mining Activity

KeyBank Invests More than $1.1 million to Support Several Non-Profit Organizations in the Capital Region
RDY

ACCESSWIRE

a year ago

KeyBank Invests More than $1.1 million to Support Several Non-Profit Organizations in the Capital Region

Costco (COST) Thrives on Business Model and Pricing Power
RDY

Zacks

a year ago

Costco (COST) Thrives on Business Model and Pricing Power

Weight loss drugs may not have as much staying power in 2024
RDY

Yahoo Finance Video

a year ago

Weight loss drugs may not have as much staying power in 2024

Hologic (HOLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
RDY

Zacks

a year ago

Hologic (HOLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Jim Cramer is Recommending These 10 Stocks
RDY

Insider Monkey

a year ago

Jim Cramer is Recommending These 10 Stocks

Alaska Airlines says the grounding of some Boeing planes will cost the airline $150 million
RDY

Associated Press Finance

a year ago

Alaska Airlines says the grounding of some Boeing planes will cost the airline $150 million

3 Reasons Roku Stock Could Crush the Market for the Next Decade
RDY

Motley Fool

a year ago

3 Reasons Roku Stock Could Crush the Market for the Next Decade

Celsius Holdings Inc. (CELH) Stock Declines While Market Improves: Some Information for Investors
RDY

Zacks

a year ago

Celsius Holdings Inc. (CELH) Stock Declines While Market Improves: Some Information for Investors

Vonage Research Reveals Nearly Half of Consumers Expect 24/7 Customer Service Support, Nearly Three Quarters Will Switch Businesses Following a Subpar Experience
RDY

PR Newswire

a year ago

Vonage Research Reveals Nearly Half of Consumers Expect 24/7 Customer Service Support, Nearly Three Quarters Will Switch Businesses Following a Subpar Experience

Mon Power and Potomac Edison Reach Settlement in Rate Review
RDY

PR Newswire

a year ago

Mon Power and Potomac Edison Reach Settlement in Rate Review

Beverages and Alcohol Stocks Q3 Recap: Benchmarking PepsiCo (NASDAQ:PEP)
RDY

StockStory

a year ago

Beverages and Alcohol Stocks Q3 Recap: Benchmarking PepsiCo (NASDAQ:PEP)

Is It Really Time to Give Up on Roku Stock?
RDY

Motley Fool

a year ago

Is It Really Time to Give Up on Roku Stock?

Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates
RDY

Insider Monkey

a year ago

Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates

CGI and Körber announce global partnership to enable pharmaceutical and life sciences clients to improve production operations
RDY

CNW Group

a year ago

CGI and Körber announce global partnership to enable pharmaceutical and life sciences clients to improve production operations

The Zacks Analyst Blog Highlights NVIDIA, Taiwan Semiconductor, Micron, Advanced Micro Devices and ASE Technology
RDY

Zacks

a year ago

The Zacks Analyst Blog Highlights NVIDIA, Taiwan Semiconductor, Micron, Advanced Micro Devices and ASE Technology

Share on Social Networks: